Pricing Log in Create free account

Korro Bio, Inc. (KRRO) vs Protara Therapeutics, Inc. (TARA)

Korro Bio, Inc. and Protara Therapeutics, Inc. are both Biotechnology companies. Korro Bio, Inc. and Protara Therapeutics, Inc. are of similar size ($141.8M and $137.1M). Across the 10 metrics below, Protara Therapeutics, Inc. leads on 6 and Korro Bio, Inc. on 4.

Valuation

Metric KRRO TARA Biotechnology median
P/E n/m n/m 8.50
P/S 23.51 n/m 9.71
P/B 1.46 0.88 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.38 n/m 9.21
Earnings yield (117.23%) (57.94%) (33.15%)
Free cash flow yield (45.42%) (46.79%) (25.50%)

Profitability

Metric KRRO TARA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (97.69%) (45.80%) (56.36%)
Return on assets (62.03%) (42.05%) (48.04%)
Return on invested capital 0.00% (255.06%) 0.00%

Growth

Metric KRRO TARA Biotechnology median
Revenue growth (TTM) (81.87%) — 6.02%
EPS growth (last fiscal year) (33.19%) 38.25% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRRO TARA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 9.55 10.97 4.72
Net debt to EBITDA 0.64 2.38 0.96

Dividend

Metric KRRO TARA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KRRO TARA Biotechnology median
Market cap 137.09m 141.83m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack